Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Drug-Like or Likely to be a Drug?

While general trends for ‘drug-like’ properties are interesting to observe, it is important to remember that the properties used to define ‘drug-likeness’ only have a weak relationship with the many, complex properties that govern the

Matthew Segall, Optibrium Ltd (December 2012)

Keywords: Drug-like properties Quantitative estimate of drug-likeness (QED) Multiparameter optimisation (MPO) Relative drug likelihood (RDL)

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |